Pulmonology Flashcards
Measurement of the volume of air that can be expelled from a maximally inflated lung
Force Vital Capacity (FVC)
measurement of the volume of air that can be exhaled at the end of the 1st second
Forced Expiratory Volume in one second (FEV1)
Auscultation sound described as snoring that may clear with cough: rattling low-pitch rumbling “Secretions”
Rhonchi
Auscultation sound described as high-pitched popping: not cleared by cough: During inspiration
Crackles
Auscultation sound described as whistling louder with expiration 2T narrow airways
Wheezing
Loudest over the anterior neck 2T narrowing of the larynx or trachea. (Upper airway obstruction MC)
Stridor
What is Samster’s Triad?
Asthma, Nasal polyps, and ASA/NSAID allergy
Dx tool used if PFT is non-diagnostic
Bronchoprovocation with________
Bronchoprovocation
Methacholine
Gold Standard for reversible obstruction
Pulmonary Function Test
Best and most objective way to asses asthma exacerbation severity and Tx response
Peak Expiratory Flow Rate
What PEFR % is considered responsive to treatment?
> 15% PEFR (Normal 400-600cc)
Pulse Oximetry indicative of Respiratory Distress
SPO2 <90%
Acute Exacerbation Admission criteria
- PEFR <50%
- <15% initial value (200cc)
- Revisit w/I 3 days of exacerbation
- Post-treatment failure
Acute Asthma exacerbation Discharge criteria
- PEFR >70%
- PEFR >15%
- Adequate F/U w/i 24-72 hrs
Asthma management anticholinergic/muscurinic that Inhibits vagal-mediated bronchoconstriction/ secretions
.
Synergistic B2 agonists and anticholinergics
Ipratropium
1sts Line treatment for acute asthma exacerbations. Most effective and fastest within 2-5 min.
Albuterol or Terbutaline (B2 Agonist short acting)
Anti-inflammatory: All but the mildest exacerbations should be discharged on a short course of these
Prednisone, Methyl prednisone, Prednisolone
Short course= 3-5 days
Long-Term exacerbation medications (Chronic control)
- ICS
- LABA
- Mast Cell Modifiers
- Leukotriene receptor Antagonists (LTRA)
Short-term exacerbation quick relief medications
- SABA
- Anticholinergics
- PO Corticosteroids
Exacerbation treatment that inhibits mast cell and leukotriene mediated degranulation
Inhibits acute phase cold air and exercise response
Mast Cell Modifiers (Cromolyn)
Exacerbation treatment that leukotriene-mediated neutrophil migration, capillary perm., M. contraction
Useful in asthmatics w allergic rhinitis/aspirin induced
LTRA (Montelukast or Zafirlukast)
DOC for long term , persistent chronic maintenance.
Cytokine and inflammation inhibition
ICS (Beclomethasone/ Flunisolide/Triamcinolone
Prevents symptoms especially nocturnal asthma. Used as a combo with ICS: not to be used alone.
LABA (Advair/ Salmeterol/Symbicort)
Step down off LABA should be done if asthma control is maintained _________
> 3 months
Adjunct indicated in severe asthma acts as bronchodilator
IV Magnesium
Analgesic that has sedative and bronchodilator effects
Ketamine
Anti-Ige used in severe uncontrolled asthma
FEV1 <60%
Omalizumab
Bronchodilator that improves respiratory muscle endurance. similar to caffeine.
Toxicity causes arrhythmias/seizures.
Theophylline
Intermittent Asthma severity SABA use and Nighttime awakenings.
< 2x week SABA
< 2x months at Night FEV1> 80
Mild Asthma severity SABA use and Nighttime awakenings. What %?
> 2x week (not daily)
3-4x month at night FEV1> 80%
Moderate Asthma severity SABA use and Nighttime awakenings.
Daily SABA
>1x week (not nightly) FEV1 60-80%
Severe Asthma severity SABA use and Nighttime awakenings.
Several a day SABA
Nightly FEV1 < 60%
Asthma Daily Medication Step 1
SABA PRN
Asthma Daily Medication Step 2
- SABA
- Low ICS or Cromolyn
Asthma Daily Medication Step 3
- SABA
- Low ICS
- LABA or LTRA
Asthma Daily Medication Step 4
- SABA
- Medium ICS
- LABA or LTRA
FEV1/FVC Obstructive pattern
- FEV1/FVC <70%
- FVC >80%
- > 200cc or 15% with SABA (20% if Methacholine)
Disorder with loss of elastic recoil and increased airway resistance. Alpha 1 antitrypsin deficiency genetic link.
RF- smoking/Exposure 90%
COPD (Antitrypsin protects Elastin in lungs)
Abnormal permanent enlargement of the terminal spaces. PE-hyperinflation, Barrel chest, pursed lips.
Respiratory alkalosis (Acidosis in acute exacerbations). Pink and cachectic (
Emphysema
Gold Standard Dx for COPD
PFT/Spirometry
Productive cough >3 mos X 2 consecutive years is hallmark: Chronic inflammation. Rales/rhonchi/wheezing
Cyanosis and cor pulmonale. respiratory acidosis. Increased Hct. Cyanotic & obese
Chronic Bronchitis
Chronic Bronchitis Management
Corticosteroids Oxygen- only that decreases mortality Anticholinergics Albuterol Theophylline
COPD staging
FEV1 >80 Mild
FEV1 50-79% moderate
FEV1 30-50% Severe
FEV1<30% Very Severe
Irreversible bronchial dilation 2t transmural inflammation of bronchi. destruction of muscular/elastic tissues of wall
Recurrent chronic lung infections. Productive cough with foul smelling sputum. MCC of massive hemoptysis.
H. Influenza MCC
Bronchiectasis
Bronchiectasis Dx and Treatment
High Resolution CT
MAC- Clarithromycin + Ethambutol + Corticosteroids
Empiric- Ampicillin, Bactrim, Amoxicillin
(Pseudomonas MC= Fluoroquinolone)
Physiotherapy
Autosomal recessive defective transmembrane Receptor protein prevents Cl- transport out of cell.
Thick mucus buildup in lungs, pancreas, liver, intestines, and reproductive tract.
Cystic Fibrosis
Cystic Fibrosis clinical manifestations
- At birth Ileus
- Pancreatic insufficiency (Decr. ADEK absorption)
- Recurrent Respiratory infections
- Infertility
Cystic Fibrosis Dx and Treatment
Dx- Elevated sweat chloride Test (primary) Twice >60
DNA= Definitive
Tx- B2 Ag, mucolytics, Abx, ADEK vit. and vaccinations
Clinical manifestations include Dry cough, dyspnea, CP: BL Hilar nodes LAD: Erythema Nodosum, Lupus pernio
Anterior uveitis: Cardiomyopathies: Rheumatologic: Noncaseating granulomas.
Sarcoidosis
Chronic multisystemic inflammatory, granulomatous DO 2T exaggerated T cell response–> granulomas
Sarcoidosis
Sarcoidosis Dx and Tx
CT- Ground-glass Opacities and BL Hilar LAD
Tissue Bx= Non-caseating Granulomas
Management- Corticosteroids PO (TOC)
- Methotrexate (if CS refractory)
Chronic progressive interstitial scarring 2T persistent inflammation.
CXR- ground-glass opacities and Honeycombing
Idiopathic Fibrosing Interstitial Pneumonia
No effective treatment- Lung transplant
what is the Lofgren’s syndrome triad for sarcoidosis
Erythema Nodosum
BL Hilar LAD
Polyarthralgias + Fever
Chronic Fibrotic lung disease 2T inhalation of mineral dust.
Pneumoconioses (Environmental Lung Disease)
Inhalation DO, 2T granite/slate/quartz/pottery sandblasting
Silicosis
Inhalation DO, 2T coal: CXR: small upper lobe nodules
Coal Worker’s Pneumoconiosis
Inhalation DO, 2T electronics, ceramics, fluorescent light bulbs.
Berylliosis
Inhalation DO, 2T textile or cotton exposure
Byssinosis
Inhalation DO, 2T destruction/renovation of old buildings, insulation, or ship buildings. Pleural thickening
Asbestosis
Malignant Mesothelioma of the pleura
Asbestosis